CTRI/2024/10/074600尚未招募3 期
Randomized controlled clinical trial to evaluate efficacy of local application of Sharapunkha malahar in the management of dushta vrana with special reference to infected wound
Dr Raut Rohit Ashok1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年10月15日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- To reduce size of wound
研究概览
简要总结
This study is prospective, randomized, open labelled, controlled clinical study of local application of Sharapunkha malahar daily for 7days and Assessment will be done at
0th,3rd,5th, 8th day in the treatment of Dushta vrana with special reference to infected wound.
This study is conducted as PG course at single center. The primary outcome is to study efficacy of local application of Sharapunkha malahar in the treatment of Dushta vrana special reference to infected wound.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- None
入排标准
- 年龄范围
- 20.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients of Dushta vrana
- •Wound size (30mm to 150 mm)
- •Wound of duration less than 1 year.
- •Diagnosed cases infected wound.
排除标准
- •Anaemic patients having HB less than 8gm%.
- •Bleeding disorder.
- •Asthmatic patients, steroid dependent / immunocompromised.
- •HIV and any systemic / organic disease.
- •Vrana situated over asthi, sandhi, kostha, marma, adhishatana.
- •Diabetic wounds and varicose ulcers
- •Patient with malignancy.
结局指标
主要结局
To reduce size of wound
时间窗: 7 days
次要结局
- 1.To reduce size of wound(2.To decrease Slough)
研究者
Dr Raut Rohit Ashok
Government Ayurved College and Hospital, Vajirabad, Nanded
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
To study effect of Ayurvedic formulations Vidangadi Lauha and Vastyamayantaka Ghrita Matra Basti in patients of Prameha - Type 2 Diabetes Mellitus.CTRI/2025/10/096569Dr Tejas Modhale99
尚未招募
不适用
A Study Comparing how well a new Drug (Sugammadex) helps patients wake up from Muscle Relaxants when they’ve been given Magnesium sulphate before surgeryCTRI/2025/11/097036150
招募中
2 期
Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar CancerNCT07353723Tang-Du Hospital10
尚未招募
1 期
Exploratory Clinical Study on the Safety and Efficacy of CD19X CAR-T Cell Injection in the Treatment of Relapsed/Refractory Large B-Cell LymphomaNCT07447726Institute of Hematology & Blood Diseases Hospital, China3
招募中
1 期
A Study of CNCT19 in the Treatment of Relapsed or Refractory Neurological Autoimmune DiseasesNCT07275736Juventas Cell Therapy Ltd.18